Company Overview
SYNDAX PHARMACEUTICALS INC
SNDXRevenue vs. Cost of Revenue
Revenue
Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses
Operating Income
Net Income
Net Income
Revenue
172M
2025 FY
Net Income
-285M
2025 FY
Shares Outstanding
87M
2025 FY
EPS
-3.29USD
2025 FY
Company Information
SIC Code
2834
CIK Code
1395937
Exchange
Nasdaq
Location
US